Properly folded bacterially expressed H1N1 hemagglutinin globular head and ectodomain vaccines protect ferrets against H1N1 pandemic influenza virus - Wikidata - wikimedia - TriplyDB

Properly folded bacterially expressed H1N1 hemagglutinin globular head and ectodomain vaccines protect ferrets against H1N1 pandemic influenza virus

Properly folded bacterially expressed H1N1 hemagglutinin globular head and ectodomain vaccines protect ferrets against H1N1 pandemic influenza virus

http://www.wikidata.org/entity/Q30391443

about

Structural vaccinology: structure-based design of influenza A virus hemagglutinin subtype-specific subunit vaccines Immunogenicity and efficacy of flagellin-fused vaccine candidates targeting 2009 pandemic H1N1 influenza in mice Comparative analysis of antibody induction and protection against influenza virus infection by DNA immunization with HA, HAe, and HA1 in mice.A live attenuated influenza A(H5N1) vaccine induces long-term immunity in the absence of a primary antibody response.Oral priming with replicating adenovirus serotype 4 followed by subunit H5N1 vaccine boost promotes antibody affinity maturation and expands H5N1 cross-clade neutralization.ICOS(+)PD-1(+)CXCR3(+) T follicular helper cells contribute to the generation of high-avidity antibodies following influenza vaccination.Bacterial HA1 vaccine against pandemic H5N1 influenza virus: evidence of oligomerization, hemagglutination, and cross-protective immunity in ferrets.A novel hemagglutinin protein produced in bacteria protects chickens against H5N1 highly pathogenic avian influenza viruses by inducing H5 subtype-specific neutralizing antibodies Expression of HA1 antigen of H5N1 influenza virus as a potent candidate for vaccine in bacterial system.Vaccination with Killed but Metabolically Active E. coli Over-expressing Hemagglutinin Elicits Neutralizing Antibodies to H1N1 Swine Origin Influenza A Virus MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines.Recombinant HA1 produced in E. coli forms functional oligomers and generates strain-specific SRID potency antibodies for pandemic influenza vaccines H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans.Yeast expressed recombinant Hemagglutinin protein of novel H1N1 elicits neutralising antibodies in rabbits and mice.Immune response following H1N1pdm09 vaccination: differences in antibody repertoire and avidity in young adults and elderly populations stratified by age and gender.New technologies for influenza vaccines.Influenza virus H1N1pdm09 infections in the young and old: evidence of greater antibody diversity and affinity for the hemagglutinin globular head domain (HA1 Domain) in the elderly than in young adults and children.Decreased serologic response in vaccinated military recruits during 2011 correspond to genetic drift in concurrent circulating pandemic A/H1N1 viruses.Cell-free production of trimeric influenza hemagglutinin head domain proteins as vaccine antigens.Oligomeric recombinant H5 HA1 vaccine produced in bacteria protects ferrets from homologous and heterologous wild-type H5N1 influenza challenge and controls viral loads better than subunit H5N1 vaccine by eliciting high-affinity antibodies.AID activity in B cells strongly correlates with polyclonal antibody affinity maturation in-vivo following pandemic 2009-H1N1 vaccination in humans.Heterovariant cross-reactive B-cell responses induced by the 2009 pandemic influenza virus A subtype H1N1 vaccine.Pandemic influenza vaccine: characterization of A/California/07/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stability A simple Pichia pastoris fermentation and downstream processing strategy for making recombinant pandemic Swine Origin Influenza a virus Hemagglutinin protein.Isolation of a high affinity neutralizing monoclonal antibody against 2009 pandemic H1N1 virus that binds at the 'Sa' antigenic site.Vaccination against influenza with recombinant hemagglutinin expressed by Schizochytrium sp. confers protective immunity.A baseline process for the production, recovery, and purification of bacterial influenza vaccine candidates.Antigenic and immunogenic properties of recombinant hemagglutinin proteins from H1N1 A/Brisbane/59/07 and B/Florida/04/06 when produced in various protein expression systems.Two glycosylation sites in H5N1 influenza virus hemagglutinin that affect binding preference by computer-based analysis.DNA priming prior to inactivated influenza A(H5N1) vaccination expands the antibody epitope repertoire and increases affinity maturation in a boost-interval-dependent manner in adults Nonglycosylated G-Protein Vaccine Protects against Homologous and Heterologous Respiratory Syncytial Virus (RSV) Challenge, while Glycosylated G Enhances RSV Lung Pathology and Cytokine Levels.Potency under pressure: the impact of hydrostatic pressure on antigenic properties of influenza virus hemagglutinin Phase 1 Safety and Immunogenicity Study of a Quadrivalent Seasonal Flu Vaccine Comprising Recombinant Hemagglutinin-Flagellin Fusion Proteins.Mucosal pre-exposure to Th17-inducing adjuvants exacerbates pathology after influenza infection.Evaluation of Epic® label-free technology to quantify functional recombinant hemagglutinin Expression, purification of herpes simplex virus type 1 US11 protein, and production of US11 polyclonal antibody.Comparison of the Protective Efficacy of Neutralizing Epitopes of 2009 Pandemic H1N1 Influenza Hemagglutinin.Modulation of Immunogenicity and Conformation of HA1 Subunit of Influenza A Virus H1/N1 Hemagglutinin in Tubular Immunostimulating Complexes.Production of Influenza Virus HA1 Harboring Native-Like Epitopes by Pichia pastoris.A nonfusogenic antigen mimic of influenza hemagglutinin glycoproteins constituted with soluble full-length HA1 and truncated HA2 proteins expressed in E. coli.

P2860

Q27676658-9FF83630-1EEF-4892-9299-6F467B9199A6 Q28743887-D5F1C5A3-496D-4357-9682-378DE450BBDA Q30354612-44637476-3AEC-4B1D-940B-BD42007A8C08 Q30359896-01C4D4A8-6B19-4D98-A941-82CECB9E594E Q30371162-AFA29E22-2910-4CD2-8792-FEA075CB11E3 Q30388557-81165D99-B9B1-4E4F-8281-7E4E8D98180E Q30396343-9951D750-7F9E-4D37-8974-75338442057E Q30398811-E24EAEC2-EB76-4AFB-BC55-659C3167F77E Q30398957-95B3EF7D-2530-429C-A00E-FD2D0061F764 Q30401849-06408FBF-5EC1-4F54-9289-C66A820D8D57 Q30403361-419B2ECE-5D5F-4449-B26D-C6EB0BBD99F4 Q30404218-D0607A35-F61F-47DD-94EF-164E311D3614 Q30406365-FECF406B-29D2-4870-9D23-081F21238807 Q30410094-042F96BD-D16E-4682-9DD3-35039D1E9D71 Q30411189-03FC7DB2-4C53-4A3D-8408-EB75504F9B04 Q30411859-447661DC-1BDB-48CB-A2E7-879059C993F1 Q30413677-86546D9F-2B44-48E9-A7D9-2B1096739E5F Q30415565-9FB6C0EB-7374-4285-B6C1-41318A8A7E6A Q30418486-B8C7C2E7-8417-4DB5-9C5B-C8F580FC1CCF Q30420990-258326F9-B93C-4C70-97F4-61BE24EBDCBF Q30421821-DA956D25-2C29-4D59-A8F8-CD29753B033A Q30422951-A65FAD6C-4410-497B-9BDB-138DF09651E4 Q30422979-C450D1A1-C8DF-4103-9A9E-C8CCEF7190ED Q30424895-18597AE6-621D-4839-9553-FEA56C3BE05B Q30426806-4B60FD51-D959-4CA7-A083-96EBF485F4D0 Q30429880-6B0B2A0D-EC9A-46D0-9D8C-4E1013B5FB97 Q30431659-95748B5D-816C-4C6E-A182-2872D8365E59 Q30517014-32F9F662-D327-4EFB-A9A4-B75A70733124 Q34311977-46DBB633-5623-4ECF-BE21-2F24DB989C0F Q34697537-B3AECAA0-3DC4-4283-B5B4-EF02856F818D Q35914345-0F6C23A8-6977-4FF6-9767-0CC924FA156B Q36251638-EDF9A0E3-0A84-439C-A526-0097B7147A19 Q36615539-1B7198AB-5952-4811-88C9-0F94A351F008 Q37415460-0F1BACAF-0A40-4E56-9C97-729E982AEE78 Q38379390-BAE5DC46-46F1-45C6-A6F2-753DA2A77BF4 Q39157648-DBA41B72-493A-4EEA-B5D7-94C8E6933814 Q40039860-9FDEEE60-2EBD-404D-B9A3-A96512F8A121 Q40059101-8C02D71D-6F05-4855-9C35-FA33CEFB5B5B Q40730375-80FBCCC8-F554-4938-B6BF-DD275421A267 Q42184367-97BCFF91-4974-4E24-8AE1-C3AB7C7B6AE2

P2860

Properly folded bacterially expressed H1N1 hemagglutinin globular head and ectodomain vaccines protect ferrets against H1N1 pandemic influenza virus

http://www.wikidata.org/entity/Q30391443

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Properly folded bacterially ex ...... H1N1 pandemic influenza virus

@ast

Properly folded bacterially ex ...... H1N1 pandemic influenza virus

@en

type

label

Properly folded bacterially ex ...... H1N1 pandemic influenza virus

@ast

Properly folded bacterially ex ...... H1N1 pandemic influenza virus

@en

prefLabel

Properly folded bacterially ex ...... H1N1 pandemic influenza virus

@ast

Properly folded bacterially ex ...... H1N1 pandemic influenza virus

@en

P1433

Q30391443-75A39CAF-F1EC-4BAC-866D-1F2E9C06E801

P1476

Q30391443-96A70546-0B83-4F5C-880F-D5F06A1FB732

P2093

Q30391443-07AECA2B-87F0-4CDE-B441-A9CD939B383D

Q30391443-1F9FBED7-86AA-4F03-B565-34A0D7DF4952

Q30391443-308A3D77-4E4A-422B-85FD-0CF0B96263CE

Q30391443-65F805BD-A6D6-464B-817A-90605C40D04A

Q30391443-7B08E14D-28E0-4A6B-8BEE-A94AABF3C2B5

Q30391443-903A2CB4-D7D3-4D6B-9527-A93824CB6B85

Q30391443-91F5ABB1-F0F7-46DE-8378-6ACB34E53603

Q30391443-9B047964-0486-408E-B508-20071F8061A5

Q30391443-F38D91F6-D7FA-4A8C-A523-DC6F5C514F98

P2860

Q30391443-172CC273-4491-4E37-A4B6-2A4FA5F4DB50

Q30391443-176B25E3-16A0-4330-A098-33D6337BF186

Q30391443-17DD6564-98D8-45EF-B48A-3052F41B23F0

Q30391443-22BC96F2-3FDD-480A-81E2-AA303E7B293D

Q30391443-236AD8A1-046F-4E52-9768-0D4914EC46B5

Q30391443-3076053B-E5FF-4B9F-8CE3-4E36402CECA6

Q30391443-3E7719F8-60E2-452B-8DDF-C296DB59EC54

Q30391443-478D29B8-8097-4A2F-8379-E9ED6C12BF9F

Q30391443-5BA9221B-6402-447A-8A06-1829D6A49591

Q30391443-5DF684E5-306D-4304-BDE9-ACF0898ECA85

P304

Q30391443-3A608B28-B614-486B-9D0E-72FE87F98014

P31

Q30391443-3FB70D95-FA5F-4B62-8023-667D0A22B7A5

P356

Q30391443-BD97D1E0-5987-4456-BE90-45318E75E246

P407

Q30391443-C425F634-DFE3-469F-9FF8-617909D31F86

P433

Q30391443-18A9FE1B-3701-4D3D-9FE9-FA7ABD6E2CD2

P478

Q30391443-08655F9C-3D19-4AA0-988E-B0B363D1DB60

P577

Q30391443-1E7CFE8F-6326-4A90-8EE4-6B87AF93C0BD

P5875

Q30391443-41AC858F-1BFF-42D4-A87E-081B2C55A07A

P698

Q30391443-1EAFA819-735B-4C40-8D9C-C9E64F8B7C34

P921

Q30391443-B49775FD-9802-4677-90E6-5F134B7F2495

P932

Q30391443-9161ACD0-4342-4A01-91C4-C82693F3C4A7

P356

JOURNAL.PONE.0011548

P1433

P1476

Properly folded bacterially ex ...... H1N1 pandemic influenza virus

@en

P2093

Corey J Crevar

http://www.w3.org/2001/XMLSchema#string

Donald M Carter

http://www.w3.org/2001/XMLSchema#string

Hana Golding

http://www.w3.org/2001/XMLSchema#string

Jody Manischewitz

http://www.w3.org/2001/XMLSchema#string

Lisa R King

http://www.w3.org/2001/XMLSchema#string

Nitin Verma

http://www.w3.org/2001/XMLSchema#string

Surender Khurana

http://www.w3.org/2001/XMLSchema#string

Swati Verma

http://www.w3.org/2001/XMLSchema#string

Ted M Ross

http://www.w3.org/2001/XMLSchema#string

P2860

H5N1 vaccine-specific B cell responses in ferrets primed with live attenuated seasonal influenza vaccines

Vaccines and antiviral drugs in pandemic preparedness

Evaluation of the efficacy and cross-protectivity of recent human and swine vaccines against the pandemic (H1N1) 2009 virus infection

Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic

Efficacious recombinant influenza vaccines produced by high yield bacterial expression: a solution to global pandemic and seasonal needs.

Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets

Dating the emergence of pandemic influenza viruses

Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus

Assessment of the efficacy of commercially available and candidate vaccines against a pandemic H1N1 2009 virus.

Modeling host responses in ferrets during A/California/07/2009 influenza infection.

P304

e11548

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0011548

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45200529

http://www.w3.org/2001/XMLSchema#string

P698

20634959

http://www.w3.org/2001/XMLSchema#string

P921

P932

2902520

http://www.w3.org/2001/XMLSchema#string